Correct option is C
Correct Answer: C. Ashwagandha
The Ministry of AYUSH collaborated with the London School of Hygiene & Tropical Medicine (LSHTM) to conduct a clinical study on Ashwagandha (Withania somnifera) for promoting recovery from COVID-19.Ashwagandha, commonly known as Indian winter cherry, is a traditional herb in Ayurvedic medicine, reputed for boosting energy, reducing stress, and strengthening the immune system.
- Study Design:A randomized, double-blind, placebo-controlled trial involving 2,000 participants diagnosed with long COVID in the UK.
- Duration:Participants receive 500 mg Ashwagandha tablets twice daily for three months.
- Objective:To evaluate Ashwagandha's efficacy in improving functional status, quality of life, and alleviating long COVID symptoms.
- Significance:This is the first instance where the Ministry of AYUSH has collaborated with a foreign institution to investigate Ashwagandha's efficacy on COVID-19 patients.
- Gotu Kola (Incorrect):Known as Centella asiatica, used in traditional medicine for wound healing and cognitive enhancement, but not studied for COVID-19 recovery.
- Boswellia (Incorrect):Also called Indian frankincense, used for its anti-inflammatory properties, but not linked to COVID-19 recovery studies.
- Brahmi (Incorrect):Known as Bacopa monnieri, traditionally used to enhance memory and cognitive function, but not associated with COVID-19 recovery research.